Superiority Trial Evaluating Digitalized Information Media for Patients With Advanced Sarcomas Receiving Systemic Treatment.
Recruiting now · Not applicable
Conditions studied: Sarcoma Metastatic, Locally Advanced Soft Tissue Sarcoma
In brief
ePPS-2202 is a study designed to evaluate the benefits of a dematerialised personalised care plan (PCP) compared to standard information/PCP for patients with advanced sarcomas receiving systemic treatment. Participants will be randomised to an experimental group or a control group. Patients in the experimental group will receive the dematerialised PCP in addition to the standard PCP while patients in the control group will receive the standard PCP alone. All patients will be followed until the end of second-line treatment, the start of a new line of treatment, or until the 24-month follow-up.
Key facts
- Study ID
- NCT06211257
- Run by
- Centre Oscar Lambret
- People needed
- 377
- Starts
- 2024-05-29
- Expected to finish
- 2030-04-01
- Last updated by the study team
- 2026-03-18
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Sarcomas of soft tissues or viscera ;
- Inoperable metastatic or locally advanced disease ;
- Indication for systemic treatment with pazopanib, trabectedine, eribulin, ifosfamide or dacarbazine monotherapy ;
- Patient covered by French social security ;
- Written, signed, informed consent ;
You may not qualify if…
- Prior inclusion in ePPS trial for a prior systemic treatment ;
- Poor understanding of French ;
- Difficulty accessing a computer ;
- Pregnant or nursing woman ;
- Person deprived of liberty or under guardianship ;
- Impossibility of undergoing medical follow-up for geographical, social or psychological reasons.
Where it is running
- Gustave Roussy — Villejuif, Île-de-France Region, France (enrolling)
- CHU Jean Minjoz — Besançon, Bourgogne-Franche-Comté, France (enrolling)
- Centre Oscar Lambret — Lille, Hauts-de-France, France (enrolling)
- CHU de Poitiers — Poitiers, New Aquitaine, France (enrolling)
- Institut de Cancérologie de l'Ouest — Saint-Herblain, Pays de la Loire Region, France (enrolling)
- Centre Léon Bérard — Lyon, Auvergne-Rhône-Alpes, France (enrolling)
- Centre Paul Strauss — Strasbourg, Grand Est, France (enrolling)
- Centre Eugène Marquis — Rennes, Brittany Region, France
- Institut Claudius Regaud — Toulouse, Occitanie, France
- Hôpital Pitié-Salpêtrière AP-HP — Paris, Île-de-France Region, France
- Institut de Cancérologie de Lorraine — Vandœuvre-lès-Nancy, France
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.